학술논문
Are monoclonals the only panacea for treatment of aquaporin-4 positive NMOSD? Experience from a low-&middle-income (LMIC) region
Document Type
Article
Author
Source
In Clinical Neurology and Neurosurgery April 2024 239
Subject
Language
ISSN
0303-8467